Abstract:The system-wide site-specific analysis of intact glycopeptides is crucial for understanding the exact functional relevance of protein glycosylation. A dedicated workflow with the capability to simultaneously characterize and quantify intact glycopeptides in a site-specific and high-throughput manner is essential to reveal specific glycosylation alteration patterns in complex biological systems. In this study, an enhanced, dedicated, large-scale site-specific quantitative N-glycoproteomics workflow has been established, which includes improved specific extraction of membrane-bound glycoproteins using the filter aided sample preparation (FASP) method, enhanced enrichment of N-glycopeptides using sequential hydrophilic interaction liquid chromatography (HILIC) and multi-lectin affinity (MLA) enrichment, sitespecific N-glycopeptide characterization enabled by EThcD, relative quantitation utilizing isobaric N, Ndimethyl leucine (DiLeu) tags and automated FDR-based large-scale data analysis by Byonic. For the first time, our study shows that HILIC complements to a very large extent to MLA enrichment with only 20% overlapping in enriching intact N-glycopeptides. When applying the developed workflow to site-specific N-glycoproteome study in PANC1 cells, we were able to identify 1067 intact N-glycopeptides, representing 311 glycosylation sites and 88 glycan compositions from 205 glycoproteins. We further applied this approach to study the glycosylation alterations in PKM2 knockout cells vs. parental breast cancer cells and revealed altered N-glycoprotein/N-glycopeptide patterns and very different glycosylation microheterogeneity for different types of glycans. To obtain a more comprehensive map of glycoprotein alterations, N-glycopeptides after treatment with PNGase F were also analyzed. A total of 484 deglycosylated peptides were quantified, among which 81 deglycosylated peptides from 70 glycoproteins showed significant changes. KEGG pathway analysis revealed that the PI3K/Akt signaling pathway was highly enriched, which provided evidence to support the previous finding that PKM2 knockdown cancer cells rely on activation of Akt for their survival. With glycosylation being one of the most important signaling modulators, our results provide additional evidence that signaling pathways are closely regulated by metabolism.

Comparative site-specific N-glycoproteome analysis reveals aberrant N-glycosylation and gives insights into mannose-6-phosphate pathway in cancer

Comparative analyses of the N-glycoproteomes in HCT116 cancer cells and their non-tumorigenic DNMT1/3b double knockout (DKO1) cells and insight into the Mannose-6-phosphate pathway

Glycosylation in the Tumor Immune Response: the Bitter Side of Sweetness

Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.

Site-specific Characterization and Quantitation of N-glycopeptides in PKM2 Knockout Breast Cancer Cells Using DiLeu Isobaric Tags Enabled by Electron-Transfer/higher-energy Collision Dissociation (Ethcd)

O-GlcNAcylation of G6PD Promotes the Pentose Phosphate Pathway and Tumor Growth

Comparative Analysis of Site-Specific N-glycosylation of LAMP1 from Breast Cancer Tissues

In-Depth Analysis of the N-Glycome of Colorectal Cancer Cell Lines

Differential O- and Glycosphingolipid Glycosylation in Human Pancreatic Adenocarcinoma Cells with Opposite Morphology and Metastatic Behavior

Mass spectrometry analysis of intact protein N-glycosylation signatures of cells and sera in pancreatic adenocarcinomas

Analysis of mutation‐originated gain‐of‐glycosylation using mass spectrometry‐based N‐glycoproteomics

Cell Surface-Specific N-glycan Profiling in Breast Cancer.

O-glycan recognition and function in mice and human cancers

Mass Spectrometry Analysis Reveals Aberrant N-glycans in Colorectal Cancer Tissues

Integration of the Transcriptome and Glycome for Identification of Glycan Cell Signatures

Metabolomics and C Labelled Glucose Tracing to Identify Carbon Incorporation into Aberrant Cell Membrane Glycans in Cancer

Aberrant Glycosylation And Cancer Biomarker Discovery: A Promising And Thorny Journey

An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry

High-Mannose N-Glycans as Malignant Progression Markers in Early-Stage Colorectal Cancer

Biomarker Discovery via N-Glycoproteomics

N-glycoproteome Analysis of the Secretome of Human Metastatic Hepatocellular Carcinoma Cell Lines Combining Hydrazide Chemistry, HILIC Enrichment and Mass Spectrometry